IPO Journey

BIOLARGO, INC.

IPO Date: April 17, 2026 · 6 filings tracked

Final Offer Terms

Ticker
BLGO
Exchange
OTCQX Best Market
Shares Offered
30,000,000
Underwriters

Led by Clearthink Capital Partners, LLC

Filing Timeline

1
424B4 Material Update
April 25, 2025
  • Diverse technology portfolio spanning PFAS water remediation, odor control, and antimicrobial wound care.
  • Flagship 'CupriDyne Clean' product provides established revenue stream in the waste management sector.
2
424B4 Material Update
June 11, 2025
  • Diversified environmental technology portfolio including water treatment, odor control, and air filtration.
  • Proprietary AEC system technology specifically designed to remove 'forever chemicals' (PFAS) from water.

Changes from previous filing

  • Shares offered: 34,888,449
3
S-1
April 9, 2026
  • Diverse technology portfolio spanning odor control, water treatment, and energy storage
  • Proprietary AEC system achieves 99% success rate in removing PFAS 'forever chemicals'

Changes from previous filing

  • Ticker symbol removed
4
S-1
April 9, 2026
  • Innovative technology portfolio targeting high-demand sectors like PFAS water remediation.
  • Diversified revenue streams including product sales, engineering services, and future licensing royalties.
5
424B4 Material Update
April 17, 2026
  • Innovative 'problem-solving lab' model targeting high-demand sectors like PFAS water remediation.
  • Diverse portfolio of proprietary technologies, including the Aqueous Electrostatic Concentrator (AEC) and Cellinity™ liquid sodium batteries.

Changes from previous filing

  • Ticker symbol: BLGO
  • Exchange: OTCQX Best Market
  • Shares offered: 31,730,651
424B4 Final Pricing
April 17, 2026
  • Diversified technology incubator spanning environmental, medical, and battery sectors.
  • Proprietary AEC technology targeting the high-demand PFAS 'forever chemicals' market.

Changes from previous filing

  • Shares offered: 30,000,000
  • Underwriters: Clearthink Capital Partners, LLC
Disclaimer: AI-generated analysis for informational purposes only. Not financial advice. Always conduct your own research.